The revenue also represents a 39 percent increase from revenues in the third quarter of 2012. Domestic revenues from 2012 fourth quarter are approximately $3 million with international revenue at $1.1 million.
In 2013, providers can begin using the new Category 1 code for the company’s AxiaLIF technology.
More Articles on Devices:
ArthroCAD Completes Financing Round for Total Hip Arthroplasty Development
Hydrocision’s Spine Device Now Available for Herniated Disc Pain Relief
FDA Grants Clearance to Two VertiFlex Spine Systems
